Table of Content


Introduction
Myelodysplastic Syndrome - Overview
Myelodysplastic Syndrome - Therapeutics Development
Myelodysplastic Syndrome - Therapeutics Assessment
Myelodysplastic Syndrome - Companies Involved in Therapeutics Development
Myelodysplastic Syndrome - Drug Profiles
Myelodysplastic Syndrome - Dormant Projects
Myelodysplastic Syndrome - Discontinued Products
Myelodysplastic Syndrome - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Myelodysplastic Syndrome, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Myelodysplastic Syndrome, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Myelodysplastic Syndrome - Pipeline by 4SC AG, H1 2020
Myelodysplastic Syndrome - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2020
Myelodysplastic Syndrome - Pipeline by AbbVie Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Acceleron Pharma Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Acrotech Biopharma LLC, H1 2020
Myelodysplastic Syndrome - Pipeline by Actinium Pharmaceuticals Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Aeglea BioTherapeutics Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Agios Pharmaceuticals Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by AIMM Therapeutics BV, H1 2020
Myelodysplastic Syndrome - Pipeline by ALX Oncology Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Amphivena Therapeutics Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Angiocrine Bioscience Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Anhui Anke Biotechnology (Group) Co Ltd, H1 2020
Myelodysplastic Syndrome - Pipeline by Apogenix AG, H1 2020
Myelodysplastic Syndrome - Pipeline by Aprea Therapeutics AB, H1 2020
Myelodysplastic Syndrome - Pipeline by AptaBio Therapeutics Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Aptevo Therapeutics Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Aptose Biosciences Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by Y-Biologics Inc, H1 2020
Myelodysplastic Syndrome - Pipeline by ZIOPHARM Oncology Inc, H1 2020
Myelodysplastic Syndrome - Dormant Projects, H1 2020
Myelodysplastic Syndrome - Discontinued Products, H1 2020